The Emergent Microbiome: A Revolution for the Life Sciences – Part VI, Diagnostics
May 25th, 2016 by Jessica Miles | News | Recent News & Articles | The Emergent Microbiome Series |
With the passage of the Patient Protection and Affordable Care Act (PPACA) in 2010, preventive medicine – services that focus on disease prevention, rather than disease treatment – became a major focus of healthcare and the market for medical diagnostics expanded to meet a growing demand. During the same time, faster and less expensive next-generation DNA sequencing (NGS) and improvements in cloud storage, which facilitated the analysis of sequence data, boosted the development of microbiome-based diagnostics.